Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mridula Dogra"'
Autor:
Jorge Alsina-Fernandez, Matthew R. Hayes, Arianna White, Ricardo J. Samms, Benjamin C. Reiner, Misgana Y. Ghidewon, Ankur Bamezai, Mridula Dogra, Samantha M. Fortin, Tito Borner, Caroline E. Geisler, Harvey J. Grill, Richard Cosgrove, Richard C. Crist, Jane Gaisinsky, Marcos J. Sanchez-Navarro, Sarah A. Doebley, Bart C. De Jonghe, Minrong Ai, Rosa M Leon
Publikováno v:
Diabetes. 70:2545-2553
Glucagon-like peptide 1 receptor (GLP-1R) agonists decrease body weight and improve glycemic control in obesity and diabetes. Patient compliance and maximal efficacy of GLP-1 therapeutics are limited by adverse side effects, including nausea and emes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfb9f6ef8d0bb54518f3a06649518dc2
https://doi.org/10.2337/db21-0459
https://doi.org/10.2337/db21-0459
Autor:
Ricardo J. Samms, Richard Cosgrove, Brandy M. Snider, Ellen C. Furber, Brian A. Droz, Daniel A. Briere, James Dunbar, Mridula Dogra, Jorge Alsina-Fernandez, Tito Borner, Bart C. De Jonghe, Matthew R. Hayes, Tamer Coskun, Kyle W. Sloop, Paul J. Emmerson, Minrong Ai
Publikováno v:
Diabetes. 71(7)
The induction of nausea and emesis is a major barrier to maximizing the weight loss profile of obesity medications, and therefore, identifying mechanisms that improve tolerability could result in added therapeutic benefit. The development of Peptide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99f9dd85499b95673bebf33dad3347bd
https://pubmed.ncbi.nlm.nih.gov/35499381
https://pubmed.ncbi.nlm.nih.gov/35499381
Autor:
Matthew R. Hayes, Bart C. De Jonghe, Ricardo J. Samms, Minrong Ai, Benjamin C. Reiner, Richard C. Crist, Harvey J. Grill, Misgana Y. Ghidewon, Ankur Bamezai, Arianna White, Jane Gaisinsky, Rosa M. Leon, Marcos J. Sanchez-Navarro, Sarah Doebley, Mridula Dogra, Jorge Alsina-Fernandez, Richard Cosgrove, Samantha M. Fortin, Caroline E. Geisler, Tito Borner
Glucagon-like peptide-1 receptor (GLP-1R) agonists decrease body weight and improve glycemic control in obesity and diabetes. Patient compliance and maximal efficacy of GLP-1 therapeutics are limited by side effects including nausea and emesis. In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6a260ce889c6586c882a9fe3e8594d5
https://doi.org/10.2337/figshare.15125112
https://doi.org/10.2337/figshare.15125112
Autor:
Liyun Ding, Matthew P. Coghlan, Ellen P.S. Conceição Furber, Jorge Alsina-Fernandez, Kyle W. Sloop, Brian A. Droz, Mridula Dogra, Annie M. Long, Michael E. Christe, Tamer Coskun, Ruth E. Gimeno, Xiaoping Ruan, Jill A. Willency, William C. Roell, Debra L. Konkol, Adrienne K. Holland, Ricardo J. Samms, Jessica L. Friedrich, Libbey S. O’Farrell, Valentina Pirro, Over Cabrera, Daniel A. Briere, Richard Cosgrove, Samantha Wojnicki, Kyla A.L. Collins, Julie S. Moyers, Yanzhu Lin, Christine C. Cheng
Publikováno v:
J Clin Invest
Tirzepatide (LY3298176), a dual GIP and GLP-1 receptor (GLP-1R) agonist, delivered superior glycemic control and weight loss compared with GLP-1R agonism in patients with type 2 diabetes. However, the mechanism by which tirzepatide improves efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a4281cb2d7c4426d2de7cba245f46e9
https://doi.org/10.1172/jci146353
https://doi.org/10.1172/jci146353
Publikováno v:
Physics and Chemistry of Glasses: European Journal of Glass Science and Technology Part B. 59:293-300
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0dd200394ed50260086b126d8ff40e22
https://doi.org/10.13036/17533562.59.6.056
https://doi.org/10.13036/17533562.59.6.056
Autor:
Vikas Anand, Parminder Kaur, Prabhjot Singh, Mridula Dogra, Bikramjit Singh Bajwa, Kuljinder Singh, Kulwinder Kaur
Publikováno v:
Radiation Physics and Chemistry. 144:171-179
In the present study, quaternary system of the composition (0.45 + x) Bi2O3-(0.25 − x) BaO-0.15 B2O3-0.15 Na2O (where 0 ≤ x ≤ 0.2 mol fraction) has been prepared by using melt-quenching technique for investigation of gamma ray shielding propert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2701e73d33361b734f17361a38aee4e6
https://doi.org/10.1016/j.radphyschem.2017.08.008
https://doi.org/10.1016/j.radphyschem.2017.08.008
Publikováno v:
Universal Journal of Physics and Application. 11:190-195
Gamma ray sources and radioactive materials in several sectors including nuclear power plants, nuclear reactors, nuclear medicine, agriculture and industry have harmful effects on humans and it is essential to provide shield against gamma radiations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cecfcbd59ce4f2d7fda0a5763db3f01f
https://doi.org/10.13189/ujpa.2017.110508
https://doi.org/10.13189/ujpa.2017.110508
Publikováno v:
AIP Conference Proceedings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ec4b07dc586589591db37bc8d28dfbb
https://doi.org/10.1063/1.5032880
https://doi.org/10.1063/1.5032880
Publikováno v:
AIP Conference Proceedings.
The present study is aimed at developing new shielding materials for gamma ray shielding applications. Transparent glasses of the composition xMoO3-0.7PbO-(0.3-x)B2O3 where x= 0.03 to 0. 06 (mole fraction) have been prepared by using melt-quenchingte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f85f2149d6a81b600addbcf11ee34ceb
https://doi.org/10.1063/1.5028821
https://doi.org/10.1063/1.5028821
Publikováno v:
AIP Conference Proceedings.
The present work has been undertaken to study the gamma ray shielding properties of PbO-P2O5-Na2WO4 glass system. The values of mass attenuation coefficient and half value layer parameter at photon energies 511, 662 and 1173 KeV have been determined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dea4b7a67075d877cc047ac18c634132
https://doi.org/10.1063/1.4980454
https://doi.org/10.1063/1.4980454